agilon health, inc.
AGL NYSE· Services-Misc Health & Allied Services, Nec
Last close · Oct 23, 2026
$89.71
KIRA · Stoqly’s AI analyst, in plain words
- agilon health, inc. had $5.9B of revenue in fiscal 2025, down 2.1% on the year before. Over five years, revenue changed +37.2% a year on average.
- Its operating margin was −7.8%, down 3.0 pts: of every 100 in sales, about −8 is left after running the business.
- agilon health, inc. lost $391M in fiscal 2025.
- Free cash flow was −$119M in fiscal 2025, −2.0% of revenue.
- agilon health, inc. has $139M more cash than debt.
Market cap
$1.5B
P/E
—
Revenue
$5.9B
Net income
−$391M
Free cash flow
−$119M
Operating margin
−7.8%
agilon health, inc. in 30 seconds · fiscal 2025
Are sales growing?
−2.1%
No. Sales fell 2.1% last year.
Does it make a profit?
−6.6%
No. It lost money last year.
Does profit turn into cash?
−2.0%
No. It spent more cash than it brought in.
How healthy are the accounts?
2 / 8
Weak. It passes 2 of 8 health tests.
What agilon health, inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 25, 2026
- Legal name
- agilon health, inc.
- CIK
- 0001831097
agilon health, inc. · AGL
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $1.5B | $2.4B | $4.3B | $6.1B | $5.9B |
| Revenue growth | 24.9% | 57.0% | 80.7% | 40.4% | −2.1% |
| Operating margin | −24.5% | −4.4% | −5.4% | −4.8% | −7.8% |
| Net income | −$406M | −$107M | −$263M | −$260M | −$391M |
| Net margin | −26.7% | −4.5% | −6.1% | −4.3% | −6.6% |
| Cash | |||||
| Cash from operations | −$148M | −$131M | −$156M | −$57.8M | −$106M |
| Capital expenditure | $6.6M | $15.4M | $15.8M | $13.3M | $13.2M |
| Free cash flow | −$155M | −$146M | −$172M | −$71.0M | −$119M |
| FCF margin | −10.2% | −6.1% | −4.0% | −1.2% | −2.0% |
| Share buybacks | — | — | $200M | — | — |
| Share count change | 15.3% | 9.4% | 0.2% | 0.5% | 0.7% |
| Debt and strength | |||||
| Cash and short-term investments | $1.0B | $877M | $108M | $188M | $174M |
| Debt incl. finance leases | $48.8M | $43.8M | $38.6M | $34.9M | $35.0M |
| Shareholders' equity | $1.1B | $1.0B | $662M | $471M | $127M |
| Current ratio | 3.8x | 2.7x | 1.5x | 1.3x | 1.0x |
| Interest coverage | −60.6x | −23.5x | −34.9x | −47.3x | −69.8x |
| Returns and quality | |||||
| Return on capital | −292.3% | −40.1% | −30.9% | −72.7% | — |
| Return on equity | −100.7% | −10.0% | −30.8% | −45.9% | −131.0% |
| Return on tangible equity | −40.9% | −10.4% | −45.8% | −69.6% | −641.5% |
| Piotroski F-score | 3 | 3 | 3 | 4 | 2 |
| Altman Z'' | 3.0 | 2.7 | −0.8 | −2.6 | −7.3 |
Insiders bought, 12 months
$0.4M
2 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
agilon health, inc. · AGL
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $89.71 a share, the company is worth $1.5B.
Source: SEC EDGAR XBRL filings (CIK 0001831097). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.